Humana Inc. (NYSE:HUM) has made a 9.03% comeback from a 12-month low price of $260. It was seen 3.07% higher, changing the price to $283.47, when the closing bell rang on 01/11/2019. At recent session, the prices were hovering between $275.2 and $284.77. This company shares are 31.02% off its target price of $371.4 and the current market capitalization stands at $39.04B. The recent change has given its price a -7.69% deficit over SMA 50 and -20.35% deficit over its 52-week high. The stock witnessed -7.38% declines, -13.79% declines and -10.21% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found HUM’s volatility during a week at 2.49% and during a month it has been found around 3.2%.Humana Inc. (HUM) Top Holders
Institutional investors currently hold around $36.27 billion or 95.9% in HUM stock. Look at its top three institutional owners. Fmr Llc owns $3.51 billion in Humana Inc., which represents roughly 8.99% of the company’s market cap and approximately 9.68% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 12,311,736 shares of the stock are valued at $3.49 billion. The third largest holder is Vanguard Group Inc, which currently holds $2.86 billion worth of this stock and that ownership represents nearly 7.34% of its market capitalization.
At the end of September reporting period, 321 institutional holders increased their position in Humana Inc. (NYSE:HUM) by some 13,381,832 shares, 323 decreased positions by 13,629,948 and 125 held positions by 100,931,037. That puts total institutional holdings at 127,942,817 shares, according to SEC filings. The stock grabbed 74 new institutional investments totaling 408,481 shares while 41 institutional investors sold out their entire positions totaling 669,916 shares.Humana Inc. (NYSE:HUM) Insider Trades
Multiple company employees have indulged in significant insider trading. Humana Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Corp. Affairs Officer Margulis Heidi S has sold 2,656 shares of Humana Inc. (HUM) in trading session dated Dec. 18, 2018. These shares are worth $786,760 and were traded at $296.22 each. The SEC filing shows that Fleming William Kevin performed a sale of 2,043 shares. The Seg President, Healthcare Svcs disposed these shares by way of transaction on Dec. 18, 2018. The company’s shares were given away at $295.03 per share worth to an income of some $602,746 on account of Fleming William Kevin.
Chief HR Officer, Huval Timothy S., sold 1,758 common shares of Humana Inc. (HUM) in the open market. In a transaction dated Dec. 18, 2018, the shares were put up for sale at an average price of $305.07, raking in a sum of $536,313. After this sale, 8,831 common shares of HUM are directly owned by the insider, with total stake valued at $2,503,324.
In the transaction dated Dec. 18, 2018, the great number of shares disposed came courtesy the Chief Information Officer; Leclaire Brian P. disposed a total of 1,474 shares at an average price of $299.29, amounting to approximately $441,153. The insider now directly owns 7,692 shares worth $2,180,451.
Several analysts have released their opinion on Humana Inc. (NYSE:HUM), with 8 analysts believing it is a strong buy. Whereas 7 of them predict the stock is a hold. Also, there are 7 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.95 average brokerage recommendation.